Latest Breaking News On - Akorn consumer health - Page 1 : comparemela.com

Share: Acquisition adds TheraTears brand to Company s leading eye care portfolio Acquisition expected to add approximately $60 and $20 million of Revenue and EBITDA, respectively on an annual basis Transaction expected to close during fiscal 2Q TARRYTOWN, N.Y., May 27, 2021 (GLOBE NEWSWIRE) Prestige Consumer Healthcare Inc. ( Prestige or the Company ) (NYSE:PBH) today announced that it has entered into a definitive agreement to acquire a portfolio of over-the-counter consumer brands from specialty pharmaceutical company Akorn Operating Company LLC ( Akorn ) for $230 million in cash. The agreement is structured as an asset purchase that delivers anticipated tax benefits of ~$30 million and expected annual EBITDA of ~$20 million equating to a transaction valued at less than 10x pro-forma EBITDA. The transaction is estimated to add annual Revenues, Earnings Per Share and Operating Cash Flow of approximately $60 million, $0.10 and $13 million, respectively.

Phil terpolilliJeffrey gilbardRon lombardiExchange commissionCompany annual report on formAkorn operating companyReed smithAkorn consumer healthPrestige consumer healthcare incConsumer healthcareEarnings per shareOperating cash flowClear eyesChief executive officerPrestige consumerHart scott rodino antitrust improvements act